Cargando…
Clinical Trials in Alzheimer's Disease: A Hurdle in the Path of Remedy
Human clinical trials seek to ameliorate the disease states and symptomatic progression of illnesses that, as of yet, are largely untreatable according to clinical standards. Ideally, clinical trials test “disease-modifying drugs,” i.e., therapeutic agents that specifically modify pathological featu...
Autores principales: | Oxford, Alexandra E., Stewart, Erica S., Rohn, Troy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152954/ https://www.ncbi.nlm.nih.gov/pubmed/32308993 http://dx.doi.org/10.1155/2020/5380346 |
Ejemplares similares
-
Immunotherapy for Alzheimer’s disease: hoops and hurdles
por: Lemere, Cynthia A
Publicado: (2013) -
Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s Disease
por: Rohn, Troy T.
Publicado: (2013) -
The Triggering Receptor Expressed on Myeloid Cells 2: “TREM-ming” the Inflammatory Component Associated with Alzheimer's Disease
por: Rohn, Troy T.
Publicado: (2013) -
Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action(1)
por: Hole, Katriona L., et al.
Publicado: (2021) -
Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles
por: Furfaro, Lucy L., et al.
Publicado: (2018)